Clinical implication of HLA class I expression in breast cancer
about
Peptide intra-tumor injection for cancer immunotherapy: enhancement of tumor cell antigenicity is a novel and attractive strategyClinical implication of human leukocyte antigen (HLA)-F expression in breast cancerPlasma membrane proteomics of human breast cancer cell lines identifies potential targets for breast cancer diagnosis and treatment.Human leukocyte antigen typing using a knowledge base coupled with a high-throughput oligonucleotide probe array analysis.Prognosis of treatment response (pathological complete response) in breast cancer.Whole Exome Sequencing of Growing and Non-Growing Cutaneous Neurofibromas from a Single Patient with Neurofibromatosis Type 1Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapy.The immune system and inflammation in breast cancer.Prognostic significance of HLA EMR8-5 immunohistochemically analyzed expression in osteosarcoma.Comprehensive transcriptome profiling of squamous cell carcinoma of horn in Bos indicus.Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes.Antigen processing and immune regulation in the response to tumours.Immunosenescence: limitations of natural killer cell-based cancer immunotherapy.SPECTRA: An Integrated Knowledge Base for Comparing Tissue and Tumor-Specific PPI Networks in Human.Clinical implications of human leukocyte antigen class I expression in endometrial cancer.HLA-G polymorphism and breast cancer.Graph-theoretical comparison of normal and tumor networks in identifying BRCA genes.Aggressive Behavior in Silent Subtype III Pituitary Adenomas May Depend on Suppression of Local Immune Response: A Whole Transcriptome Analysis.Cancerous HLA class I expression and regulatory T cell infiltration in gastric cancer.Single nucleotide variant profiles of viable single circulating tumour cells reveal CTC behaviours in breast cancer.Gemcitabine alters the proteasome composition and immunopeptidome of tumour cells.Prognostic values of the mRNA expression of natural killer receptor ligands and their association with clinicopathological features in breast cancer patients.The Role of Immune Escape and Immune Cell Infiltration in Breast CancerTumors with a more complex genome have a higher frequency of HLA class I total loss: a unifying pan-cancer hypothesisImmunopeptidomic Profiling of HLA-A2-Positive Triple Negative Breast Cancer Identifies Potential Immunotherapy Target Antigens
P2860
Q27020970-28476946-9D94-42AB-999E-00A6F1A6F700Q28266906-28BB3A23-313C-4751-86BE-B0E94237F18EQ33910532-55E4D2DB-FE92-4133-A29A-9226B1EE372DQ34579653-6BCFA9DC-D560-4F29-9996-F124C8F552A3Q35971135-47723C52-2E9B-40AE-A125-CAC6C267CF59Q36252643-ACD21652-BBD9-4346-8C91-3E7F652B0D7BQ36759294-4302A361-0912-4224-A00E-B7CCB2D925DCQ37033451-804884AE-A84B-4E9B-92DC-3F8C4B55F0D2Q37703330-7EAA2F18-C922-4D46-A4AC-BFDAAFC6ECC9Q38482331-1D16FAE2-56E9-4C35-AABF-88E9CC9C57D6Q38547141-DEC7ED7C-FD6C-4A15-B7F7-E9A8F5E8449DQ38818628-550EA929-1B25-44C0-AB59-4B4980608BE1Q38928938-DA9C0A10-BED5-4C55-850F-B0A9BB2DBFCEQ40451360-D878F3BE-42B7-4E44-B19D-8FBEB68E5920Q43147365-3CD489BC-EE1F-4780-9AEB-584E84CB740EQ45261570-319168DA-F838-4B9C-9338-C2928A584617Q47322786-35799D22-3463-48D9-A20D-9C634EC1FBE0Q47784194-2A497A04-C9CC-4096-A965-BEBA56478709Q50960953-E8CD96C3-2479-4C5A-AD2B-17E00D90797FQ52724992-2C075714-BB1D-4204-84F1-90D548277526Q55364385-6D5000BF-2012-4342-9061-3BE177510AF7Q55405564-DBE2927B-B838-446A-8F5B-77E0BB67BD7FQ57114285-33B2A557-2690-4E40-AE35-CF92896E97B5Q58050251-D88AACF6-E48A-4654-ADBF-C6635E49779CQ58214193-B979012E-7F84-4B88-89E7-68C288AAD99C
P2860
Clinical implication of HLA class I expression in breast cancer
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Clinical implication of HLA class I expression in breast cancer
@ast
Clinical implication of HLA class I expression in breast cancer
@en
Clinical implication of HLA class I expression in breast cancer
@nl
type
label
Clinical implication of HLA class I expression in breast cancer
@ast
Clinical implication of HLA class I expression in breast cancer
@en
Clinical implication of HLA class I expression in breast cancer
@nl
prefLabel
Clinical implication of HLA class I expression in breast cancer
@ast
Clinical implication of HLA class I expression in breast cancer
@en
Clinical implication of HLA class I expression in breast cancer
@nl
P2093
P2860
P356
P1433
P1476
Clinical implication of HLA class I expression in breast cancer
@en
P2093
Chihaya Koriyama
Heiji Yoshinaka
Hiroshi Okumura
Hiroyuki Shinchi
Koichi Kaneko
Munetsugu Hirata
Shinichi Ueno
Shoji Natsugoe
Sumiya Ishigami
Yawara Funasako
P2860
P2888
P356
10.1186/1471-2407-11-454
P407
P577
2011-10-20T00:00:00Z
P5875
P6179
1000291030